Medical Writing - read more

 

All AMS  medical writers are scientists; most of them have postgraduate qualifications in Life Sciences.

Regulatory documents (investigator’s brochures, study protocols, observation plans, patient information, amendments, diaries/questionnaires, study reports) and publications of scientific results (abstracts, posters, manuscripts) are prepared according to your ideas and concepts with the utmost flexibility even within demanding timelines.

 

AMS  assets are:

AMS  has a large team of medical writers with expertise in a broad range of indications – from A as auto-injector to T as transthyretin familial amyloid polyneuropathy or U as ulcerative colitis, with emphasis on oncologic indications or Medical Devices.

Understanding the different needs of experts, professionals and lay people enables our medical writers to present complex data and scientific contexts in a comprehensible and informative manner.

Personal experience in clinical research and close collaboration with the AMS  clinical operations experts permits our medical writers to give valuable input and support right from the very beginning of a study by drafting intelligent study outlines and protocols according to your specifications.

Continuing education and training (e.g. via professional networks EMWA, AMWA).

In case of involvement of AMS  data management and biostatistics or pharmacovigilance, AMS’ lean management structure offers quick and direct inter-departmental communication.

AMS  medical writers support you as external team members in close cooperation with your project managers, scientific experts, and statisticians.

Contact AMS  early for ideal support.

 

Find out how AMS  Medical Writing services fit to your needs:

Contact us: 

Medicalwriting bottom

• 2011 – AMS AMNOG Services pioneer • 2013 – AMS-Investigator SELF-TRAINING PORTAL • 2013 – “BEST CRO” by one of ther world’s Top 5 Pharma companies’ CRO Evaluation for AMS – Clinical Operations Services • 2014 – AMS performs Medical App Studies including eCRF-data integration • 2015 – AMS Medical Science is awarded “Provider of the Year, worldwide” the world’s Top 10 Pharma companies • 2015 – AMS develops an E-feasibility tool • 2015 – Innovative Tool for Patient Reported Outcomes: AMS-ePRO (BYOD-type PRO solution) is developed • 2016 – AMS – Regulatory Affairs is nominated on the short-list for TOPRA Award for Regulatory Excellence

News

  • EUnetHTA Open Call for Early Dialogue Requests

    EUnetHTA Open Call for Early Dialogue...

    Informationen
    Artikel vom 09 Juli 2020 News
    EUnetHTA’s Joint Action 3 has been prolonged to May 31, 2021. After a temporary suspension of Early Dialogues (ED) due to the current pandemic situation, ED...
  • EUnetHTA publishes the second iteration of the EUnetHTA Prioritisation List (EPL)

    EUnetHTA publishes the second...

    Informationen
    Artikel vom 01 August 2019 News
    It’s time to get involved: EUnetHTA publishes the second iteration of the EUnetHTA Prioritisation List (EPL) EUnetHTA’s Joint Action 3 will definitely end in...
  • EMA-EUnetHTA Parallel Consultation

    EMA-EUnetHTA Parallel Consultation

    Informationen
    Artikel vom 01 August 2017 News
    Profit from the simultaneous feedback of regulatory and HTA bodies in order to generate your data set in the most efficient way! What is new? EMA and EUnetHTA have...
  • AbbVie TRIUMPH AWARD 2015

    AbbVie TRIUMPH AWARD 2015

    Informationen
    Artikel vom 24 Juni 2016 News
    Um Kooperationen auszuzeichnen und Partner entsprechend zu honorieren, verleiht AbbVie Global jährlich den Preis 'Supplier of the Year'. Kriterien, um für den...
  • AMS electronic Patient Reported Outcomes (AMS-ePRO®)

    AMS electronic Patient Reported...

    Informationen
    Artikel vom 01 Juni 2016 News
    AMS electronic Patient Reported Outcomes (AMS-ePRO®) AMS-ePRO® supports Clinical Research You can now capture your patients data Anytime Anywhere with...